Clinical Trial Detail

NCT ID NCT03009240
Title Pevonedistat and Decitabine in Treating Patients With High Risk Acute Myeloid Leukemia
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors City of Hope Medical Center
Indications

acute myeloid leukemia

Therapies

Decitabine + MLN4924

Age Groups: senior adult

No variant requirements are available.